Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001681098-25-000005
Filing Date
2025-10-10
Accepted
2025-10-10 19:17:35
Documents
1
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1760138252.html 4  
1 FORM 4 wk-form4_1760138252.xml 4 7401
  Complete submission text file 0001681098-25-000005.txt   9053
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
McFarlane Neil F. (Reporting) CIK: 0001681098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 251388985